Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068418 · ClinicalTrials.gov registry record · NA
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01068418 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 26 participants.
The verdict
NCT01068418, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Hypothesis: Vitamin D supplementation lower renin-angiotensin system activity in obesity. Specific Aim: To investigate whether Vitamin D supplementation in obesity improves the vascular sensitivity to angiotensin II.
Interventions
- DIETARY_SUPPLEMENT Vitamin D (cholecalciferol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068418
The ClinicalTrials.gov registry entry for NCT01068418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D (cholecalciferol) is the first listed.
NCT01068418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01068418 about?
NCT01068418 is a clinical study titled "Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity". Hypothesis: Vitamin D supplementation lower renin-angiotensin system activity in obesity. Specific Aim: To investigate whether Vitamin D supplementation in obesity improves the vascular sensitivity to angiotensin II.
What is the current status of trial NCT01068418?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2010-02. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01068418?
The interventions under investigation include: Vitamin D (cholecalciferol) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01068418?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.